The partnership is another investment by the biotech subsidiary in artificial intelligence for drug discovery and development, continuing an industry trend.
This is a companion discussion topic for the original entry at https://www.biopharmadive.com/news/genentech-nvidia-biotech-ai-drug-research/700221/